Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NPB
NPB logo

NPB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Northpointe Bancshares Inc (NPB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
16.980
1 Day change
0.47%
52 Week Range
19.480
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Northpointe Bancshares Inc (NPB) does not currently present a compelling buy opportunity for a beginner, long-term investor. While the company has shown strong financial growth in the last quarter, the lack of significant trading signals, neutral technical indicators, and absence of recent positive catalysts suggest a wait-and-see approach is more prudent.

Technical Analysis

The MACD is negative and contracting (-0.0729), RSI is neutral at 54.7, and moving averages are converging. The stock is trading near its pivot point (17.043) with resistance at 17.639 and support at 16.447. No clear bullish or bearish trend is evident.

Positive Catalysts

  • Analyst price target raised to $22 with an Outperform rating.

Neutral/Negative Catalysts

  • No recent trading trends from hedge funds or insiders. Technical indicators do not show a clear upward trend. Stock trend analysis suggests potential short-term declines (-0.4% next day, -2.81% next week, -1.14% next month).

Financial Performance

In Q4 2025, Northpointe Bancshares reported strong growth: revenue increased to $62.94M (+57.19% YoY), net income rose to $18.39M (+107.96% YoY), and EPS doubled to 0.52. However, gross margin remained stagnant.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Keefe Bruyette raised the price target to $22 from $21 and maintained an Outperform rating. This indicates confidence in the stock's long-term potential but does not suggest immediate upside.

Wall Street analysts forecast NPB stock price to rise
2 Analyst Rating
Wall Street analysts forecast NPB stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 16.980
sliders
Low
20
Averages
20.5
High
21
Current: 16.980
sliders
Low
20
Averages
20.5
High
21
Keefe Bruyette
NULL -> Outperform
maintain
$21 -> $22
AI Analysis
2026-01-22
Reason
Keefe Bruyette
Price Target
$21 -> $22
AI Analysis
2026-01-22
maintain
NULL -> Outperform
Reason
Keefe Bruyette raised the firm's price target on Northpointe to $22 from $21 and keeps an Outperform rating on the shares.
Piper Sandler
Piper Sandler
Overweight
maintain
$20
2025-12-22
Reason
Piper Sandler
Piper Sandler
Price Target
$20
2025-12-22
maintain
Overweight
Reason
Piper Sandler raised the firm's price target on Northpointe to $20 from $19.50 and keeps an Overweight rating on the shares. ahead of Q4 results for the firm's mortgage finance coverage. The sector backdrop has shifted positively, driven by 30-year rates falling to 6.2% from 7%-plus highs earlier in the year and material tightening in agency spreads. While the market has not yet fully "normalized," momentum is building, Piper argues. Mortgage application volumes are rising, led by an 18% sequential and 100%-plus year-over-year surge in refinance activity. Additionally, GSE reform is likely to return to the spotlight given the administration's push for a deal under President Trump and FHFA Director Bill Pulte, it adds.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for NPB
Unlock Now

People Also Watch